No auxiliary, no byproduct strategy for water-soluble prodrugs of taxoids: Scope and limitation of O-N intramolecular acyl and acyloxy migration reactions

被引:43
作者
Skwarczynski, M [1 ]
Sohma, Y [1 ]
Noguchi, M [1 ]
Kimura, M [1 ]
Hayashi, Y [1 ]
Hamada, Y [1 ]
Kimura, T [1 ]
Kiso, Y [1 ]
机构
[1] Kyoto Pharmaceut Univ, Ctr Frontier Res Med Sci, Dept Med Chem, Yamashima Ku, Kyoto 6078412, Japan
关键词
D O I
10.1021/jm049344g
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Since numerous new taxoids active against multidrug resistant (MDR) tumors have been developed and their poor water-solubility is a very real problem in intravenous administration, we have designed and synthesized a series of novel water-soluble taxoid prodrugs (isotaxoids). These prodrugs, a 2'-O-isoform of taxoids, showed promising results with higher water solubility (0.8- 1.1 mg/mL) and proper kinetics for parent drug release by a simple pH-dependent chemical mechanism via O-N intramolecular acyl migration. No additional functional auxiliaries are released during the conversion to parent drugs, which would be an advantage in toxicology and general pharmacology, and the cost for the evaluations of auxiliary units in these fields could be saved in prodrug development. In addition, we demonstrate for the first time the successful application of the O-N intramolecular acyloxy migration reaction in the prodrug design, with the exception of the tert-butyloxycarbonyl group, and that this reaction can be provided with no organic solvent and no side products.
引用
收藏
页码:2655 / 2666
页数:12
相关论文
共 60 条
[1]  
Advani R, 2003, CLIN CANCER RES, V9, P5187
[2]   Synthesis and biological evaluation of C-3′NH/C-10 and C-2/C-10 modified paclitaxel analogues [J].
Baloglu, E ;
Hoch, JM ;
Chatterjee, SK ;
Ravindra, R ;
Bane, S ;
Kingston, DGI .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (07) :1557-1568
[3]   Pivalate-generating Prodrugs and carnitine homeostasis in man [J].
Brass, EP .
PHARMACOLOGICAL REVIEWS, 2002, 54 (04) :589-598
[4]  
Cassinelli G, 2002, CLIN CANCER RES, V8, P2647
[5]   Cascade-release dendrimers liberate all end groups upon a single triggering event in the dendritic core [J].
de Groot, FMH ;
Albrecht, C ;
Koekkoek, R ;
Beusker, PH ;
Scheeren, HW .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (37) :4490-4494
[6]   Synthesis and biological evaluation of 2′-carbamate-linked and 2′-carbonate-linked prodrugs of paclitaxel:: Selective activation by the tumor-associated protease plasmin [J].
de Groot, FMH ;
van Berkom, LWA ;
Scheeren, HW .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (16) :3093-3102
[7]   2-MONOSUBSTITUTED-1,3-OXAZOLIDINES AS IMPROVED PROTECTIVE GROUPS OF N-BOC-PHENYLISOSERINE IN DOCETAXEL PREPARATION [J].
DIDIER, E ;
FOUQUE, E ;
TAILLEPIED, I ;
COMMERCON, A .
TETRAHEDRON LETTERS, 1994, 35 (15) :2349-2352
[8]   Recent developments in antitumour taxoids [J].
Dubois, J ;
Guénard, D ;
Guéritte, F .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (12) :1809-1823
[9]   Lessons learned from marketed and investigational prodrugs [J].
Ettmayer, P ;
Amidon, GL ;
Clement, B ;
Testa, B .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) :2393-2404
[10]  
Ferlini Cristiano, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P133, DOI 10.2174/1568011033353489